AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 15 filers reported holding AVENUE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHIKIAR ASSET MANAGEMENT INC | 12,500 | $9 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $353 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,585 | $3,242 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,571 | $36,999 | 0.00% |
| STATE STREET CORP | 30,593 | $21,531 | 0.00% |
| BARRETT & COMPANY, INC. | 15 | $11 | 0.00% |
| MORGAN STANLEY | 276 | $195 | 0.00% |
| BlackRock Inc. | 1,868 | $1,321 | 0.00% |
| Bank of New York Mellon Corp | 51,572 | $36,461 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,438 | $10,208 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,876 | $4,861 | 0.00% |
| EMFO, LLC | 533 | $377 | 0.00% |
| ROYAL BANK OF CANADA | 98 | $0 | 0.00% |
| VANGUARD GROUP INC | 46,293 | $32,729 | 0.00% |
This page lists AVENUE THERAPEUTICS INC's shareholders in Q3 2023. To view AVENUE THERAPEUTICS INC's shareholder history, click here.